drugset / Trial / NCT05216770

Understanding Disorder-specific Neural Pathophysiology in Laryngeal Dystonia and Voice Tremor

NCT05216770

RandomizedParallel-groupQuadruple-blindBasic science

Summary

The researchers will examine functional neural correlates that differentiate between laryngeal dystonia and voice tremor and contribute to disorder-specific pathophysiology using a cross-disciplinary approach of multimodal brain imaging.

Timeline

Start
2022-03-24
Primary completion
2027-08-31
Completion
2027-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.75 % Topical
Comparator Bupivacaine Other / unclassified 1 ml Topical

Indications